nodes	percent_of_prediction	percent_of_DWPC	metapath
Dolasetron—Respiratory tract congestion—Varenicline—nicotine dependence	0.0553	0.068	CcSEcCtD
Dolasetron—Peripheral ischaemia—Varenicline—nicotine dependence	0.0553	0.068	CcSEcCtD
Dolasetron—Throat irritation—Varenicline—nicotine dependence	0.04	0.0492	CcSEcCtD
Dolasetron—HTR3A—Ligand-gated ion channel transport—GABRA4—nicotine dependence	0.0389	0.208	CbGpPWpGaD
Dolasetron—Electrocardiogram abnormal—Varenicline—nicotine dependence	0.0308	0.0379	CcSEcCtD
Dolasetron—Intestinal obstruction—Varenicline—nicotine dependence	0.0296	0.0364	CcSEcCtD
Dolasetron—Eructation—Varenicline—nicotine dependence	0.0198	0.0244	CcSEcCtD
Dolasetron—Influenza like illness—Varenicline—nicotine dependence	0.0196	0.0241	CcSEcCtD
Dolasetron—Photophobia—Varenicline—nicotine dependence	0.0189	0.0233	CcSEcCtD
Dolasetron—Urine output increased—Varenicline—nicotine dependence	0.0182	0.0224	CcSEcCtD
Dolasetron—Sleep disorder—Varenicline—nicotine dependence	0.0169	0.0208	CcSEcCtD
Dolasetron—Polyuria—Varenicline—nicotine dependence	0.0167	0.0205	CcSEcCtD
Dolasetron—CYP2D6—CYP2E1 reactions—CYP2A7—nicotine dependence	0.0162	0.0866	CbGpPWpGaD
Dolasetron—CYP2C9—CYP2E1 reactions—CYP2A7—nicotine dependence	0.016	0.0859	CbGpPWpGaD
Dolasetron—Renal failure acute—Varenicline—nicotine dependence	0.0159	0.0195	CcSEcCtD
Dolasetron—Increased appetite—Varenicline—nicotine dependence	0.0156	0.0192	CcSEcCtD
Dolasetron—Urinary retention—Varenicline—nicotine dependence	0.0139	0.0171	CcSEcCtD
Dolasetron—Abdominal distension—Varenicline—nicotine dependence	0.0127	0.0157	CcSEcCtD
Dolasetron—CYP2D6—Fatty acids—CYP2A7—nicotine dependence	0.0126	0.0676	CbGpPWpGaD
Dolasetron—Acute coronary syndrome—Varenicline—nicotine dependence	0.0111	0.0137	CcSEcCtD
Dolasetron—Myocardial infarction—Varenicline—nicotine dependence	0.0111	0.0136	CcSEcCtD
Dolasetron—Stomatitis—Varenicline—nicotine dependence	0.011	0.0135	CcSEcCtD
Dolasetron—Epistaxis—Varenicline—nicotine dependence	0.0106	0.0131	CcSEcCtD
Dolasetron—Bradycardia—Varenicline—nicotine dependence	0.0103	0.0127	CcSEcCtD
Dolasetron—CYP2D6—Xenobiotics—CYP2A7—nicotine dependence	0.01	0.0537	CbGpPWpGaD
Dolasetron—Oedema peripheral—Varenicline—nicotine dependence	0.00998	0.0123	CcSEcCtD
Dolasetron—CYP2C9—Xenobiotics—CYP2A7—nicotine dependence	0.00994	0.0532	CbGpPWpGaD
Dolasetron—Visual impairment—Varenicline—nicotine dependence	0.00976	0.012	CcSEcCtD
Dolasetron—Tinnitus—Varenicline—nicotine dependence	0.00945	0.0116	CcSEcCtD
Dolasetron—Chills—Varenicline—nicotine dependence	0.00909	0.0112	CcSEcCtD
Dolasetron—Arrhythmia—Varenicline—nicotine dependence	0.00905	0.0111	CcSEcCtD
Dolasetron—Flatulence—Varenicline—nicotine dependence	0.00869	0.0107	CcSEcCtD
Dolasetron—Dysgeusia—Varenicline—nicotine dependence	0.00864	0.0106	CcSEcCtD
Dolasetron—HTR3A—Ion channel transport—GABRA4—nicotine dependence	0.00844	0.0452	CbGpPWpGaD
Dolasetron—HTR3A—SIDS Susceptibility Pathways—CHRNB4—nicotine dependence	0.00834	0.0447	CbGpPWpGaD
Dolasetron—Tremor—Varenicline—nicotine dependence	0.00826	0.0102	CcSEcCtD
Dolasetron—Ill-defined disorder—Varenicline—nicotine dependence	0.00818	0.0101	CcSEcCtD
Dolasetron—Anaemia—Varenicline—nicotine dependence	0.00815	0.01	CcSEcCtD
Dolasetron—Agitation—Varenicline—nicotine dependence	0.00811	0.00997	CcSEcCtD
Dolasetron—Angioedema—Varenicline—nicotine dependence	0.00806	0.00991	CcSEcCtD
Dolasetron—Malaise—Varenicline—nicotine dependence	0.00795	0.00978	CcSEcCtD
Dolasetron—Vertigo—Varenicline—nicotine dependence	0.00792	0.00974	CcSEcCtD
Dolasetron—Syncope—Varenicline—nicotine dependence	0.00791	0.00973	CcSEcCtD
Dolasetron—Palpitations—Varenicline—nicotine dependence	0.00779	0.00958	CcSEcCtD
Dolasetron—Loss of consciousness—Varenicline—nicotine dependence	0.00775	0.00953	CcSEcCtD
Dolasetron—Cough—Varenicline—nicotine dependence	0.0077	0.00946	CcSEcCtD
Dolasetron—Convulsion—Varenicline—nicotine dependence	0.00764	0.0094	CcSEcCtD
Dolasetron—Hypertension—Varenicline—nicotine dependence	0.00762	0.00936	CcSEcCtD
Dolasetron—Myalgia—Varenicline—nicotine dependence	0.00751	0.00923	CcSEcCtD
Dolasetron—Arthralgia—Varenicline—nicotine dependence	0.00751	0.00923	CcSEcCtD
Dolasetron—Chest pain—Varenicline—nicotine dependence	0.00751	0.00923	CcSEcCtD
Dolasetron—Anxiety—Varenicline—nicotine dependence	0.00748	0.0092	CcSEcCtD
Dolasetron—Discomfort—Varenicline—nicotine dependence	0.00742	0.00912	CcSEcCtD
Dolasetron—Dry mouth—Varenicline—nicotine dependence	0.00734	0.00903	CcSEcCtD
Dolasetron—Oedema—Varenicline—nicotine dependence	0.0072	0.00885	CcSEcCtD
Dolasetron—Shock—Varenicline—nicotine dependence	0.00708	0.00871	CcSEcCtD
Dolasetron—Thrombocytopenia—Varenicline—nicotine dependence	0.00705	0.00867	CcSEcCtD
Dolasetron—Tachycardia—Varenicline—nicotine dependence	0.00703	0.00864	CcSEcCtD
Dolasetron—Hyperhidrosis—Varenicline—nicotine dependence	0.00696	0.00856	CcSEcCtD
Dolasetron—Anorexia—Varenicline—nicotine dependence	0.00686	0.00844	CcSEcCtD
Dolasetron—Hypotension—Varenicline—nicotine dependence	0.00673	0.00827	CcSEcCtD
Dolasetron—Musculoskeletal discomfort—Varenicline—nicotine dependence	0.00656	0.00806	CcSEcCtD
Dolasetron—CYP3A4—Xenobiotics—CYP2A7—nicotine dependence	0.00655	0.0351	CbGpPWpGaD
Dolasetron—Dyspnoea—Varenicline—nicotine dependence	0.00642	0.00789	CcSEcCtD
Dolasetron—Somnolence—Varenicline—nicotine dependence	0.0064	0.00787	CcSEcCtD
Dolasetron—Dyspepsia—Varenicline—nicotine dependence	0.00634	0.00779	CcSEcCtD
Dolasetron—Decreased appetite—Varenicline—nicotine dependence	0.00626	0.00769	CcSEcCtD
Dolasetron—Fatigue—Varenicline—nicotine dependence	0.00621	0.00763	CcSEcCtD
Dolasetron—Pain—Varenicline—nicotine dependence	0.00616	0.00757	CcSEcCtD
Dolasetron—Constipation—Varenicline—nicotine dependence	0.00616	0.00757	CcSEcCtD
Dolasetron—Feeling abnormal—Varenicline—nicotine dependence	0.00593	0.00729	CcSEcCtD
Dolasetron—Gastrointestinal pain—Varenicline—nicotine dependence	0.00589	0.00724	CcSEcCtD
Dolasetron—Urticaria—Varenicline—nicotine dependence	0.00572	0.00703	CcSEcCtD
Dolasetron—Abdominal pain—Varenicline—nicotine dependence	0.00569	0.007	CcSEcCtD
Dolasetron—Body temperature increased—Varenicline—nicotine dependence	0.00569	0.007	CcSEcCtD
Dolasetron—HTR3A—SIDS Susceptibility Pathways—CHRNB2—nicotine dependence	0.00557	0.0298	CbGpPWpGaD
Dolasetron—Hypersensitivity—Varenicline—nicotine dependence	0.0053	0.00652	CcSEcCtD
Dolasetron—Asthenia—Varenicline—nicotine dependence	0.00516	0.00635	CcSEcCtD
Dolasetron—Pruritus—Varenicline—nicotine dependence	0.00509	0.00626	CcSEcCtD
Dolasetron—HTR3A—SIDS Susceptibility Pathways—CHRNA4—nicotine dependence	0.00506	0.0271	CbGpPWpGaD
Dolasetron—Diarrhoea—Varenicline—nicotine dependence	0.00493	0.00606	CcSEcCtD
Dolasetron—Dizziness—Varenicline—nicotine dependence	0.00476	0.00585	CcSEcCtD
Dolasetron—Rash—Varenicline—nicotine dependence	0.00454	0.00558	CcSEcCtD
Dolasetron—Dermatitis—Varenicline—nicotine dependence	0.00453	0.00558	CcSEcCtD
Dolasetron—Headache—Varenicline—nicotine dependence	0.00451	0.00554	CcSEcCtD
Dolasetron—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00416	0.0223	CbGpPWpGaD
Dolasetron—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00413	0.0221	CbGpPWpGaD
Dolasetron—CYP2D6—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00411	0.022	CbGpPWpGaD
Dolasetron—CYP2C9—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00407	0.0218	CbGpPWpGaD
Dolasetron—CYP2D6—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00337	0.0181	CbGpPWpGaD
Dolasetron—CYP2C9—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00335	0.0179	CbGpPWpGaD
Dolasetron—HTR3A—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.00294	0.0157	CbGpPWpGaD
Dolasetron—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00272	0.0146	CbGpPWpGaD
Dolasetron—CYP3A4—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00269	0.0144	CbGpPWpGaD
Dolasetron—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00221	0.0118	CbGpPWpGaD
Dolasetron—CYP2D6—Metapathway biotransformation—AKR1B10—nicotine dependence	0.0019	0.0102	CbGpPWpGaD
Dolasetron—CYP2C9—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00189	0.0101	CbGpPWpGaD
Dolasetron—CYP2D6—Biological oxidations—CYP2A7—nicotine dependence	0.00179	0.0096	CbGpPWpGaD
Dolasetron—CYP2C9—Biological oxidations—CYP2A7—nicotine dependence	0.00178	0.00952	CbGpPWpGaD
Dolasetron—CYP2D6—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00177	0.00947	CbGpPWpGaD
Dolasetron—CYP2C9—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00175	0.00939	CbGpPWpGaD
Dolasetron—CYP3A4—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00124	0.00666	CbGpPWpGaD
Dolasetron—CYP3A4—Biological oxidations—CYP2A7—nicotine dependence	0.00117	0.00628	CbGpPWpGaD
Dolasetron—CYP3A4—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00116	0.00619	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—CYP2A7—nicotine dependence	0.000307	0.00164	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—CYP2A7—nicotine dependence	0.000304	0.00163	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—CYP2A7—nicotine dependence	0.0002	0.00107	CbGpPWpGaD
